Navigation Links
AEterna Zentaris Receives US$5.5 Million from Institutional Investors
Date:10/24/2009

rd, Quebec City, Canada G1P 4P5. This announcement is neither an offer to sell nor a solicitation of an offer to buy any of AEterna Zentaris' common shares or warrants. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.

Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., (Nasdaq: RODM), acted as the exclusive placement agent for the transaction.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any such factors or to pub
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  BioScrip, Inc. (NASDAQ: ... present at the Jefferies 2013 Global Healthcare Conference to ... New York. Richard Smith ... Hai Tran , Chief Financial Officer, will present ... Daylight Time.   About BioScrip BioScrip, ...
(Date:5/23/2013)... Graphite Metallizing Corporation announces a ... in stainless steel pillow blocks. This series combines ... the application and installation versatility of pillow blocks. ... work exceptionally well when submerged in water, water-soluble ... as acids, alkalies, hydrocarbons, black liquor, and liquid ...
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 The maker ... all types of inventions. They focus on learning practical ... this community gravitate toward bringing their ideas to life ... Biology Movement, works on making projects using biology. Glowing ... of plants to make them glow with bioluminescence genes, ...
Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2
... sector, she began to notice a certain pattern: Scientists with ... business world to be a much different place than academia, ... ,"Along the way, I realized that it was that people ... product just as effectively as a competitor," Villars said. "I ...
... Prospera , an online personnel management tool which ... professionals, the company announced Tuesday. The tool is built ... human resources staffs: plan, staff, compensate, develop and review. ... bottom line; then it illustrates, step-by-step, how to perform ...
... voted 21-12 on Wednesday, short of a veto-proof majority, to ... likely that Gov. Jim Doyle will veto the bill. , ... Sen. Jeff Plale, D-South Milwaukee, and Sen. Roger Breske, D-Eland. ... for reproductive purposes but also what proponents call therapeutic or ...
Cached Biology Technology:Can tech people be business leaders? Upcoming seminar may have the answer 2Can tech people be business leaders? Upcoming seminar may have the answer 3J.J. Keller, Modine Manufacturing, Gustave A. Larson Co., Esker, Firstlogic, Software One 2Wisconsin Senate votes to outlaw cloning; measure still faces veto 2Wisconsin Senate votes to outlaw cloning; measure still faces veto 3
(Date:5/22/2013)... major new effort to educate the public and decision ... clean water that looms ahead in the 21st century. ... current edition of Chemical & Engineering News , ... the world,s largest scientific society. , Bassam Z. Shakhashiri, ... Ph.D., explain that shortages of reliable supplies of fresh ...
(Date:5/22/2013)... DNA can endanger the whole organism, as they may ... (LMU) in Munich now report how byproducts of respiration ... The DNA in our cells controls the form and ... instructions for this are encoded in the linear sequence ... adenine (A), cytosine (C), guanine (G) and thymine (T). ...
(Date:5/22/2013)... and wild plants have slowed in recent years, according ... University of Leeds and the Naturalis Biodiversity Centre in ... the diversity of species in Britain, Belgium and the ... picture brightened markedly after 1990, with a slowdown in ... wild plants. , Professor Bill Kunin, Professor ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... A recent study demonstrated increased rates of celiac ... Published in the May-June 2011 issue of The ... female patients presenting with infertility. Each participant underwent ... infertility testing. The 4 patients who had positive ...
... Cincinnati, (OH) - The International Rett Syndrome Foundation (IRSF) ... support eight cutting-edge projects that aim to accelerate translational ... is the world,s largest private source of funding for ... IRSF has cumulatively funded over $24M in high quality, ...
... PHILADELPHIA It is helpful even life-saving to have ... system is only a few nanometers in size, having a sign ... a clever bit of molecular design by University of Pennsylvania and ... form of a simple color change. The ...
Cached Biology News:IRSF awards over $650,000 for Translational Rett Syndrome research 2Penn molecular scientists develop color-changing stress sensor 2Penn molecular scientists develop color-changing stress sensor 3
...
Phospho-Btk (Tyr223) Antibody...
...
... - Proliferation Marker, prediluted Ki67 antigen ... protein, expressed by proliferating cells in all ... S, G2 and M phase). It is ... are useful in establishing the cell growing ...
Biology Products: